SCHEMBL25211019

SCHEMBL25211019

NNc1cc(OC(F)(F)F)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.40
BRAF P15056 9/20 0.40
SCN5A Q14524 2/20 0.38
SCN9A Q15858 2/20 0.38
KCNH2 Q12809 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23763117 0.82 RXRA (0.43) KDRBRAFGPR3ABL1BCR
SCHEMBL25201725 0.79 ROCK1 (0.44) NPC1RAB9AGAAALOX15ABL1
SCHEMBL26548751 0.78 MAPK14 (0.40) KDRBRAFCYP1A2IGF1RHRH4
SCHEMBL23213851 0.77 KDR (0.49) KDRBRAFSMN1; SMN2
SCHEMBL25524510 0.76 KDR (0.39) KDRBRAFGAASMN1; SMN2ABL1
SCHEMBL30001628 0.76 NOS3 (0.57) KDR
SCHEMBL2570584 0.76 NOS3 (0.57) KDR
SCHEMBL29969144 0.76 NOS3 (0.57) SCN5ASCN9AKCNH2NPC1RAB9A
SCHEMBL23213556 0.76 NOS3 (0.57) SCN5ASCN9AKCNH2NPC1RAB9A
SCHEMBL29968592 0.74 ABL1 (0.49) SCN9AABL1BCRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed